Additional FDA funds
This article was originally published in The Tan Sheet
Executive Summary
FDA receives $150 million in additional funding for fiscal 2008 in the Supplemental Appropriations Bill of 2008, H.R. 2642, signed June 30 by President Bush. The appropriation includes $66.8 million for the Center for Food Safety and Applied Nutrition, $28 million for the Center for Drug Evaluation and Research and $12.7 million for the Center of Biologics Evaluation and Research. In an effort led by Pennsylvania Republican Arlen Specter, the Senate initially approved giving FDA $275 million in additional fiscal 2008 funding, including $125 million for food protection, but the administration vowed to veto those elevated spending levels (1"The Tan Sheet" May 26, 2008, In Brief). Meantime, House appropriators look for progress on fiscal 2009 appropriations despite partisan differences (see story, p. 9)...
You may also be interested in...
Keeping up FDA funding
The House Sept. 24 approves a continuing resolution to fund most of the federal government, including FDA, at fiscal 2008 appropriation levels through March 6, 2009. The money available to FDA will be calculated on the basis of both the level in its 2008 appropriation and the $150 million added in a supplemental funding package (1"The Tan Sheet" July 7, 2008, In Brief). As of Sept. 26, the Senate was scheduled to vote on the measure on Sept. 27. Without the continuing resolution, funding for the government would cease Oct. 1. As March approaches, Congress likely will pass another continuing resolution to fund the government through the end of fiscal 2009, a staffer notes
Supplemental FDA funding
A version of the Supplemental Appropriations Bill of 2008, H.R. 2642, passed by the Senate would provide an additional $275 million for FDA, but would likely not receive President Bush's approval, the Office of Management and Budget says May 22. The president "has made clear that he will veto a bill that ... exceeds his responsible spending levels," according to OMB Director Jim Nussle. The Senate approved the measure May 15 with $100 million in additional FDA funding to regulate drugs, devices and biologics, $50 million to modernize its science and workforce, and $125 million for food protection as well as supplement support for other domestic measures, but a same-day approval by the House did not include the additional FDA funds (1"The Tan Sheet" May 19, 2008, p. 10)...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.